SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Dexterra Group Inc. (HZNOF) trades at a trailing P/E of 13.7, forward P/E of 10.9. Trailing earnings yield is 7.28%, forward earnings yield 9.18%. PEG 0.13 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (13.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.13); earnings yield beats bond yields (7.28%).
- Forward P/E 10.9 (down from trailing 13.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.13 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 7.28% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 9.18% as earnings recover.
Overall SharesGrow Score: 57/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HZNOF
Valuation Multiples
P/E (TTM)13.7
Forward P/E10.9
PEG Ratio0.13
Forward PEG0.42
P/B Ratio0.00
P/S Ratio0.54
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.64
Forward EPS (Est.)$0.81
Book Value / Share$0.00
Revenue / Share$16.42
FCF / Share$0.00
Yields & Fair Value
Earnings Yield7.28%
Forward Earnings Yield9.18%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.74 |
$250.94M |
$-20.32M |
-8.1% |
| 2017 |
$-0.27 |
$324.08M |
$-7.84M |
-2.4% |
| 2018 |
$-0.26 |
$394.25M |
$-8.2M |
-2.1% |
| 2019 |
$0.28 |
$261.06M |
$9.02M |
3.5% |
| 2020 |
$1.24 |
$477.82M |
$64.03M |
13.4% |
| 2021 |
$0.37 |
$733.38M |
$24.36M |
3.3% |
| 2022 |
$0.05 |
$971.52M |
$3.43M |
0.4% |
| 2023 |
$0.41 |
$1.12B |
$26.62M |
2.4% |
| 2024 |
$0.31 |
$1B |
$19.87M |
2% |
| 2025 |
$0.64 |
$1.04B |
$40.48M |
3.9% |
